多西紫杉醇与多西紫杉醇联合卡铂治疗老年晚期非小细胞肺癌的疗效观察_stmopen 关键词】: 多西紫杉醇 卡铂 老年 非小细胞肺癌 单药化疗 [gap=1124]Keywords】: Docetaxel Carboplatin Elder NSCLC Monotherapy
基于1个网页-相关网页
Among monotherapy group,control rate was 51.0%,excellence rate was 22.4%,total effective rate was 83.7%;in add-on therapy group control rate was 33.3%,excellence rate was 25.6%,total effective rate was 79.5%.
单药治疗组控制率为51.0%,显效率为22.4%,总有效率为83.7%;添加治疗组控制率为33.3%,显效率为25.6%,总有效率为79.5%。
参考来源 - 丙戊酸镁缓释片治疗癫痫的临床观察·2,447,543篇论文数据,部分数据来源于NoteExpress
N a medical treatment using a single drug or therapy 单一疗法
It banned the import and sale of separate artemisinin tablets, known as oral artemisinin monotherapy, in September 2008.
单一的青蒿素药品,即口服青蒿素单一疗法已于2008年9月起被禁止进口和销售。
However, most clinical trials conducted with these agonists as monotherapy in patients with cancer have not shown a benefit.
然而,大多数临床试验这些激动剂都是单独使用的,没有显示出其治疗癌症的效应。
This is the use of a single drug (or monotherapy) of chloroquine, sulfadoxine-pyrimethamine, or another antimalarial medicine to fight malaria.
这种疗法使用氯喹、磺胺多辛-乙胺嘧啶或另一种抗疟药物等单一药物治疗疟疾(亦称单一疗法)。
应用推荐